Ivermectin, diethylcarbamazine and albendazole mass drug administration: impact on prevalence of scabies, impetigo and soil-transmitted helminth (STH) infections in three municipalities of Timor-Leste

Ivermectin, diethylcarbamazine and albendazole mass drug administration: impact on prevalence of scabies, impetigo and soil-transmitted helminth (STH) infections in three municipalities of Timor-Leste

The aim of this study was to assess the impact of the Ministry of Health’s mass drug administration programme using a triple drug therapy (ivermectin, diethylcarbamazine, albendazole), designed for controlling lymphatic filariasis, on the burden of scabies and soil-transmitted helminth infections. We visited 6 primary schools across 3 municipalities to conduct skin exams to assess scabies and collect stool samples to diagnose STH infections.

Countries South – East Asian Countries
Diseases Scabies, STH
Drugs Ivermectin, Diethylcarbamazine, Albendazole
Research Discipline Population health interventions
Main Investigator/Other Investigators Associate Professor Susana Vaz Nery Brandon Le Joshua Francis
Contact Person Associate Professor Susana Vaz Nery
Associate Investigators/Other Collaborators Professor Rebecca TraubDr Daniel EngelmanProfessor Andrew Steer, Alexander Matthews,  Salvador Amaral, Merita Monteiro, Terlinda Barros
Link to Project -
Partner Organisations or Research Institutions involved -
Approximate project duration Apr 2019 – Nov 2020